Gyre Therapeutics, a commercial-stage biopharmaceutical company, has announced its plans to acquire Cullgen Inc., a clinical-stage biopharmaceutical company, in an all-stock transaction valued at ...

Range Resources Corporation (NYSE: RRC) has announced its fourth quarter 2025 financial results and 2026 guidance, showcasing notable achievements and plans for the future. In 2025, the company ...

McEwen said its Tartan mine project in Flin Flon, Manitoba now carries an estimated 308,900 indicated gold ounces and 302,700 inferred gold ounces, based on a gold price of US$3,000 an ounce. The ...

Vistra Corp. (NYSE: VST) has announced its definitive agreement to acquire seven modern natural gas generation facilities from Lotus Infrastructure Partners, totaling approximately 2,600 MW of ...

Brookfield has recently unveiled a substantial $100 billion global AI infrastructure program, which involves the launch of the Brookfield Artificial Intelligence Infrastructure Fund (BAIIF). The fund ...

Palo Alto Networks Inc. recently filed its Annual Report on Form 10-K for fiscal 2024, showcasing its financial performance and strategic initiatives. The company's revenue for fiscal 2025 was $9.2 ...

Green Dot Corporation (NYSE: GDOT) has recently announced strategic transactions with Smith Ventures and CommerceOne Financial Corporation. The transactions involve Smith Ventures acquiring and ...

Upstream Bio, Inc. (NASDAQ: UPB) has just announced positive top-line results from the phase 2 vibrant trial evaluating Verekitug, a monoclonal antibody targeting the receptor for thymic stromal ...

Brookfield's acquisition of the remaining interest in Oaktree is a significant move that will see Brookfield owning 100% of Oaktree, a premier credit manager. The proposed transaction is valued at ...

Broadstreet, a leading North American insurance brokerage company, has announced a significant change in ownership and partnership structure. Ethos Capital, British Columbia Investment Management ...

QXO, Inc. has recently released its investor presentation for June 2025, outlining its plans and performance. The company aims to become the tech-enabled leader in the $800 billion building products ...

Apogee Therapeutics, Inc. (NASDAQ: APGE) has reported its full year 2025 financial results, showing significant progress in its pipeline and a strong financial position. The company's total cash ...